アクセス数 : ?
ダウンロード数 : ?
ID 114470
タイトル別表記
DBS for Tardive Syndrome
著者
キーワード
deep brain stimulation
globus pallidus internus
antipsychotic agents
abnormal involuntary movements
tardive dyskinesia
tardive syndrome
secondary dystonia
pathophysiology
資料タイプ
学術雑誌論文
抄録
Tardive syndrome (TDS) is a potentially permanent and irreversible hyperkinetic movement disorder caused by exposure to dopamine receptor blocking agents. Guidelines published by the American Academy of Neurology recommend pharmacological first-line treatment for TDS with clonazepam (level B), ginkgo biloba (level B), amantadine (level C), and tetrabenazine (level C). Recently, a class II study provided level C evidence for use of deep brain stimulation (DBS) of the globus pallidus internus (GPi) in patients with TDS. Although the precise pathogenesis of TDS remains to be elucidated, the beneficial effects of GPi-DBS in patients with TDS suggest that the disease may be a basal ganglia disorder. In addition to recent advances in understanding the pathophysiology of TDS, this article introduces the current use of DBS in the treatment of medically intractable TDS.
掲載誌名
Frontiers in Psychiatry
ISSN
16640640
出版者
Frontiers Media S.A.
7
開始ページ
207
発行日
2016-12-26
権利情報
© 2016 Morigaki, Mure, Kaji, Nagahiro and Goto. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY)(https://creativecommons.org/licenses/by/4.0/). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
EDB ID
出版社版DOI
出版社版URL
フルテキストファイル
言語
eng
著者版フラグ
出版社版
部局
医学系
病院